Royle Pamela, Waugh Norman
Department of Public Health, University of Aberdeen, Aberdeen, UK.
Health Info Libr J. 2004 Mar;21(1):14-20. doi: 10.1111/j.1471-1842.2004.00459.x.
Our objective was to perform a pilot study to estimate the proportion of published errata linked to randomized controlled trials (RCTs) that are worthwhile obtaining when doing a systematic review. medline was searched for records that had both 'randomized-controlled-trial' in the publication type field and 'erratum' in the comments field. One hundred records from four general medical journals were examined independently from two different perspectives. From the information specialist's perspective, 74% of the errata were considered worthwhile obtaining; these were mainly errors in tables or figures. Another 9% described less serious errors, but were worth obtaining if easily available. The other 17% were minor errors. From the perspective of the experienced reviewer/public health consultant, 5% of errata were classified as likely to affect a meta-analysis, and 10% as having significant errors that would affect the interpretation of the RCT, but no effect on a meta-analysis; 85% were not considered important enough to affect either. About 5% of errata to RCTs appeared to matter in terms of changing the final conclusions of a systematic review. However, the majority of errata were considered to be worthwhile obtaining, on the basis that having full and accurate data can reduce confusion and save reviewers time.
我们的目标是开展一项初步研究,以估计在进行系统评价时,与随机对照试验(RCT)相关的已发表勘误中值得获取的比例。在Medline中检索在出版物类型字段中有“随机对照试验”且在评论字段中有“勘误”的记录。从两个不同角度独立检查了来自四种综合医学期刊的100条记录。从信息专家的角度来看,74%的勘误被认为值得获取;这些主要是表格或图表中的错误。另外9%描述的是不太严重的错误,但如果容易获取则值得获取。其余17%是小错误。从经验丰富的评审员/公共卫生顾问的角度来看,5%的勘误被归类为可能影响荟萃分析,10%有重大错误会影响RCT的解释,但对荟萃分析没有影响;85%被认为不够重要,不会影响两者。约5%的RCT勘误似乎会改变系统评价的最终结论。然而,大多数勘误被认为值得获取,因为拥有完整准确的数据可以减少混淆并节省评审员的时间。